Antibiotics

Glucoallosamidin A is a glycoside antibiotic produced by the strain of Streptomyces sp. SA-684. It can inhibit Chitinase activity.

Glucoallosamidin B is a glycoside antibiotic produced by the strain of Streptomyces sp. SA-684. It can inhibit Chitinase activity.

It is produced by the strain of Micridispora sp. TP-A0184. It has anti-gram positive bacteria, negative bacteria and yeast activity, but lower than Questiomycin.

It is produced by the strain of Aspergillus flavipes F-2090/7. It is a glutarimide antibiotic. It has anti-gram-positive bacteria, negative bacteria and fungi (individual) activity.

It is produced by the strain of Nocardia sp. MG615-7F6. It is a glycoside cinnamyl imide histamine antibiotic. It has the activity of anti-gram positive bacteria and negative bacteria. It inhibits leukemia L1210 cell with IC50 of 2.0 μg/mL.

It is produced by the strain of Sebekia sp. LL-14E605 (NRRL 21083). It is a peptide antibiotic. It has strong activity against gram-positive bacteria including methicillin-resistant staphylococcus aureus (MRSA) and vancomycin resistant enterococcus (VREF), MIC is 0.03-0.06 μg/mL.

It is produced by the strain of Basidiomycetes sp. It is a glycoside antibiotic.

It is produced by the strain of Basidiomycetes sp. It is a glycoside antibiotic, and has anti-gram-positive bacterial activity.

It is produced by the strain of Bacillus cereus Nos. F173-B61 and F262-B54. It has anti-gram positive bacteria and negative bacteria (including aminoglycoside antibiotic resistant bacteria) activity, the antibacterial activity of main component Glysperin A is 2-4 times stronger than B and C.

It is produced by the strain of Bacillus cereus Nos. F173-B61 and F262-B54. It has anti-gram positive bacteria and negative bacteria (including aminoglycoside antibiotic resistant bacteria) activity, the antibacterial activity of main component Glysperin A is 2-4 times stronger than B and C.

It is produced by the strain of Bacillus cereus Nos. F173-B61 and F262-B54. It has anti-gram positive bacteria and negative bacteria (including aminoglycoside antibiotic resistant bacteria) activity, the antibacterial activity of main component Glysperin A is 2-4 times stronger than B and C.

It is produced by the strain of Streptomyces gougerotii 21544. It has weak activity against gram-positive bacteria, negative bacteria and mycobacterium, and can inhibit Newcastle disease virus, vaccinia virus, pseudorabies virus and western equine encephalomyelitis virus.

It is produced by the strain of Cytospora sp. W. F. P. L. 13A (ATCC20502). It has weak activity against gram-positive bacteria, negative bacteria, cyanobacteria and green algae.

It is produced by the strain of Bacillus brevis. It mainly has anti-gram-positive bacterial activity.

It is produced by the strain of Streptomyces olvaceus var. ETH 7437, Str. violaceoruber. It inhibits the initial stage of RNA biosynthesis, has anti-gram-positive bacteria, Mycobacterium (weak) and vaginal trichomonas activity, but also can inhibit tumor cells.

It is produced by the strain of Streptomyces sp. XT-11989. It's a quinone antibiotic. It has anti-gram-positive bacterial activity.

It is produced by the strain of Streptomyces lateritius (ZIMET 43646). It's a quinone antibiotic. It has anti-gram positive bacteria and negative bacteria activity.

It is produced by the strain of Streptomyces californicus JA-2640 and Str. griseus (FCRC-57). It is a quinone antibiotic. It mainly has anti-gram-positive bacterial activity.

It is produced by the strain of Streptomyces californicus JA-2640 and Str. griseus (FCRC-57). It is a quinone antibiotic. It mainly has anti-gram-positive bacteria and negative bacteria (individual) activity.

It is produced by the strain of Streptomyces californicus JA-2640 and Str. griseus (FCRC-57). It is a quinone antibiotic. It has antitumor activity.